Lee Kalowski

Insider Reports History

Location
Waltham, MA
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lee Kalowski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Q32 Bio Inc. CFO and President Stock Option (Right to Buy) 161,323 $2,164,955 $13.42 24 Feb 2025 Direct
BICYCLE THERAPEUTICS plc President and CFO Ordinary Shares 30,309 $530,408 $17.50 03 Apr 2023 Direct
Q32 Bio Inc. CFO and President Common Stock 39,938 $138,213 $3.46 02 Dec 2025 Direct

Insider Reports Filed by Lee Kalowski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QTTB Q32 Bio Inc. 02 Dec 2025 1 -$31,395 4 CFO and President 04 Dec 2025, 19:00
QTTB Q32 Bio Inc. 26 Aug 2025 1 -$7,636 4 CFO and President 28 Aug 2025, 19:20
QTTB Q32 Bio Inc. 24 Feb 2025 5 $0 4 CFO and President 27 Feb 2025, 06:01
QTTB Homology Medicines, Inc. 25 Mar 2024 1 $0 4 CFO and President 27 Mar 2024, 17:34
QTTB Homology Medicines, Inc. 25 Mar 2024 0 $0 3 CFO and President 27 Mar 2024, 17:18
BCYC BICYCLE THERAPEUTICS plc 03 Apr 2023 1 -$7,937 4 President and CFO 05 Apr 2023, 16:41
BCYC BICYCLE THERAPEUTICS plc 03 Jan 2023 3 -$52,744 4 President and CFO 05 Jan 2023, 20:12
BCYC BICYCLE THERAPEUTICS plc 03 Jan 2022 2 $0 4 President and CFO 05 Jan 2022, 16:20
BCYC BICYCLE THERAPEUTICS plc 02 Sep 2021 3 -$301,800 4 President and CFO 03 Sep 2021, 16:49
BCYC BICYCLE THERAPEUTICS plc 26 Aug 2021 6 -$224,493 4 President and CFO 27 Aug 2021, 18:31
BCYC BICYCLE THERAPEUTICS plc 23 Aug 2021 3 -$235,650 4 President and CFO 25 Aug 2021, 17:45
BCYC BICYCLE THERAPEUTICS plc 29 Jul 2021 5 -$373,448 4 President and CFO 30 Jul 2021, 18:21